| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/11/2012 | US8263067 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 09/11/2012 | US8262054 Furnace mount |
| 09/11/2012 | CA2534120C Medicaments for inhalation comprising anticholinergics and a betamimetic |
| 09/11/2012 | CA2532450C Chlorthalidone combinations |
| 09/11/2012 | CA2526570C Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant |
| 09/11/2012 | CA2480881C Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
| 09/11/2012 | CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same |
| 09/07/2012 | WO2012119056A1 Proteasome inhibitor delanzomib for use in the treatment of lupus |
| 09/07/2012 | WO2012118172A1 Drug for improving central functions during pain |
| 09/07/2012 | WO2012118042A1 Medicinal agent for inhibiting metastasis of malignant tumor |
| 09/07/2012 | WO2012116997A1 TREATMENT OF ARTERIAL AGEING BY HMG CoA REDUCTASE INHIBITOR |
| 09/07/2012 | WO2012091571A3 Combination of components for the prevention and treatment of frailty |
| 09/07/2012 | CA2828971A1 Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it |
| 09/07/2012 | CA2827653A1 Proteasome inhibitor delanzomib for use in the treatment of lupus |
| 09/06/2012 | US20120226347 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 09/06/2012 | US20120225955 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin |
| 09/06/2012 | US20120225940 Use of (-) (3-Trihalomethylphenoxy) (4-Halophenyl) Acetic Acid Derivatives for Treatment of Insulin Resistance, Type 2 Diabetes, Hyperlipidemia and Hyperuricemia |
| 09/06/2012 | US20120225928 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 09/06/2012 | US20120225853 Hormone replacement therapy and depression |
| 09/06/2012 | US20120225031 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 09/06/2012 | US20120225030 Uses of mammalian cytokine; related reagents |
| 09/05/2012 | EP2495569A1 Method for determination of sensitivity to anti-cancer agent |
| 09/05/2012 | EP2495568A1 Method for determining sensitivity to an anticancer agent |
| 09/05/2012 | EP2495561A1 Anticancer agent sensitivity-determining marker |
| 09/05/2012 | EP2495324A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 09/05/2012 | EP2495245A2 Gram-positive carbapenem antibacterials and processes for their preparation |
| 09/05/2012 | EP2494992A1 Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events |
| 09/05/2012 | EP2494991A1 Combination therapy for the treatment of HCV infection |
| 09/05/2012 | EP2494990A1 Agent for regeneration and/or protection of nerves |
| 09/05/2012 | EP2494968A1 Compound, in particular dermatological ointment with Olea Europaea Fruit Oil and Silver |
| 09/05/2012 | EP2494967A1 Novel composition for treating metabolic syndrome |
| 09/05/2012 | EP2494964A1 Combinations of valsartan and amlodipine |
| 09/05/2012 | EP2494963A1 Combinations of valsartan and amlodipine |
| 09/05/2012 | EP2493466A1 Novel antitumoral use of cabazitaxel |
| 09/05/2012 | EP2493465A2 Treatment of sunburn using analgesics and antihistamines |
| 09/05/2012 | EP2493464A1 Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms |
| 09/05/2012 | EP2493315A1 Dimethyl sulfoxide (dmso) or dmso and methylsulfonylmethane (msm) formulations to treat infectious diseases |
| 09/05/2012 | EP2493312A1 Solid pharmaceutical compositions containing an integrase inhibitor |
| 09/05/2012 | EP2493298A1 The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders |
| 09/05/2012 | CN1639569B Methods and compositions for inducing an immune response |
| 09/05/2012 | CN1635909B Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 09/05/2012 | CN1165483B Compositions of ciplatin in comination with 2,2'-dithio-bis (ethanesulfonate) (dinesna) |
| 09/05/2012 | CN102655881A Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
| 09/05/2012 | CN102655873A Combinations of a specific HCV NS5A inhibitor and an HCV NS3 protease inhibitor |
| 09/05/2012 | CN102655868A Combination preparations comprising a cytokine antagonist and corticosteroid |
| 09/05/2012 | CN102655864A Compositions and methods for treating centrally mediated nausea and vomiting |
| 09/05/2012 | CN102655861A Combination for the treatment of radiation- or chemotherapy-induced mucositis |
| 09/05/2012 | CN102652732A Nano water-soluble emulsion and preparation method thereof |
| 09/05/2012 | CN102652729A Magnetic nanomaterials and methods for chemoembolisation |
| 09/05/2012 | CN101822832B Composition with anti-tumor effect and application thereof in preparing medicament for treating tumor |
| 09/05/2012 | CN101773479B Method for preparing shell-core double-layer microspheres |
| 09/05/2012 | CN101690822B Medicament carrier for targeted medicament delivery on diseases related to macrophage and preparation method thereof |
| 09/05/2012 | CN101642570B Application of carbon monoxide-releasing molecules and heparin in preparing medicament for treating sepsis |
| 09/05/2012 | CN101583377B Treatment of fibrosis |
| 09/05/2012 | CN101443016B Use of 4, 17 beta-dihydroxyandrost-4-ene-3-one for treating cancers |
| 09/05/2012 | CN101437501B Prolongation of survival of an allograft by inhibiting complement activity |
| 09/05/2012 | CN101360486B Nanoparticles for protein drug delivery |
| 09/05/2012 | CN101340947B Combination of an iap-inhibitor and a taxane7 |
| 09/05/2012 | CN101267838B Use of a DPP-IV inhibitor to reduce hypoglycemic events |
| 09/05/2012 | CN101014613B Chimpanzee adenovirus vaccine carriers |
| 09/04/2012 | US8258255 Phosphorus-containing compounds with polymeric chains, and methods of making and using the same |
| 09/04/2012 | US8258125 HDL-boosting combination therapy complexes |
| 09/04/2012 | US8258106 Immunostimulatory nucleic acid molecules |
| 09/04/2012 | US8257730 Steroid-containing sustained release intraocular implants and related methods |
| 09/04/2012 | US8257709 Antibodies against Clostridium difficile toxins and uses thereof |
| 09/04/2012 | US8257693 Composition for maintaining healthy kidney function |
| 09/04/2012 | US8257691 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 09/04/2012 | CA2432971C Polypeptides |
| 08/30/2012 | WO2012116278A1 Cannabinoid receptor modulators |
| 08/30/2012 | WO2012116277A1 Cannabinoid receptor modulators |
| 08/30/2012 | US20120220558 Methods of Treating Hormone-Related Conditions Using Thio-Oxindole Derivatives |
| 08/30/2012 | US20120219601 Composition Comprising Biodegradable Hydrating Ceramics for Controlled Drug Delivery |
| 08/30/2012 | US20120219593 Indolylmaleimide derivatives processes for their production and pharmaceutical compositions |
| 08/30/2012 | US20120219592 Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain |
| 08/29/2012 | EP2491928A2 Therapeutic agent for vitiligo and method of accelerating pigmentation |
| 08/29/2012 | EP2491926A1 Treatment of protein degradation disorders |
| 08/29/2012 | EP2491800A1 Improved stability in vitamin and mineral supplements |
| 08/29/2012 | EP2490689A2 Injectable formulations for intra- articular or peri-articular administration |
| 08/29/2012 | EP2490688A1 Combination cancer therapy with hsp90 inhibitory compounds |
| 08/29/2012 | EP2490687A1 Compositions for treatment of cystic fibrosis and other chronic diseases |
| 08/29/2012 | EP2490682A1 Derivatives of n-hydroxybenzamide for treating hiv infections |
| 08/29/2012 | EP2490680A2 Neuroprotection and myelin repair using nestorone® |
| 08/29/2012 | EP2490678A1 Coated capsules and tablets of a fatty acid oil mixture |
| 08/29/2012 | EP2490534A1 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone |
| 08/29/2012 | CN1997395B Drug having regulatory cell ligand contained in liposome |
| 08/29/2012 | CN1841066B Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 08/29/2012 | CN1735435B Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 08/29/2012 | CN102652020A Combination preparations comprising exosomes and corticosteroid |
| 08/29/2012 | CN102648980A Colonic purgative composition with soluble binding agent |
| 08/29/2012 | CN102099026B Therapeutic compositions containing macitentan |
| 08/29/2012 | CN101778608B Artificial insemination device in mammal reproduction |
| 08/29/2012 | CN101633646B Salts of valsartan |
| 08/29/2012 | CN101564383B Skin external used patch |
| 08/29/2012 | CN101426807B Neuroprotective compounds and uses thereof |
| 08/29/2012 | CN101318019B Compositions and methods for the therapy of inflammatory bowel disease |
| 08/29/2012 | CN101028519B Pharmaceutical composition for treating immune diseases |
| 08/28/2012 | US8252923 Peptidomimetic protease inhibitors |
| 08/28/2012 | US8252814 Agents and crystals for improving excretory potency of urinary bladder |
| 08/28/2012 | US8252585 Neural progenitor cell populations |
| 08/28/2012 | US8252524 Method of screening pharmaceutical compositions that promote nuclear transfer of Cdc42 protein |